investerms.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | Investerms.com |
| Description | Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over Media Kit Sponsors Partners Home Companies Feature Story Top News Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 98.129.229.182 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
investerms.com Valuation
|
US$268,583
Last updated: 2023-05-12 11:30:39
investerms.com has Semrush global rank of 39,408,014. investerms.com has an estimated worth of US$ 268,583, based on its estimated Ads revenue. investerms.com receives approximately 30,991 unique visitors each day. Its web server is located in United States, with IP address 98.129.229.182. According to SiteAdvisor, investerms.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$268,583 |
| Daily Ads Revenue | US$248 |
| Monthly Ads Revenue | US$7,438 |
| Yearly Ads Revenue | US$89,253 |
| Daily Unique Visitors | 2,067 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| investerms.com. | A | 3599 | IP: 98.129.229.182 |
| investerms.com. | NS | 3600 | NS Record: dns2.stabletransit.com. |
| investerms.com. | NS | 3600 | NS Record: dns1.stabletransit.com. |
| investerms.com. | MX | 3600 | MX Record: 10 mx1.emailsrvr.com. |
| investerms.com. | MX | 3600 | MX Record: 20 mx2.emailsrvr.com. |
HtmlToTextCheckTime:2023-05-12 11:30:39
| Media Kit Sponsors Partners Home Companies Feature Story Top News Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options Tuesday, March 2, 2021 · Paul Archie Big Pharma Dives Into CBD: Who Could Be Next? Monday, February 22, 2021 · Paul Archie Clinical Trials Focus on COVID-19 and Acute Myocarditis Tuesday, January 19, 2021 · Paul Archie Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™ Tuesday, December 22, 2020 · Paul Archie Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Tuesday, December 15, 2020 · Paul Archie Interviews Features News Markets --> Newsletter Don’t Miss Out Get weekly updates on the biotech industry and opportunities straight to your inbox. Browse Topics --> Recent Articles Cardiol Therapeutics Submits Application for Uplisting to |
HTTP Headers
HTTP/1.1 200 OK Server: Apache/2.4 Content-Type: text/html; charset=UTF-8 Date: Wed, 15 Dec 2021 08:53:11 GMT X-Pingback: http://investerms.com/xmlrpc.php Transfer-Encoding: chunked Connection: Keep-Alive Set-Cookie: X-Mapping-ocpcmbel=60DD1B05FEBB5847EE727DBD50A93E93; path=/ Set-Cookie: PHPSESSID=e7add208caa08607fa2ed029058c4dea; path=/ |
investerms.com Whois Information
Domain Name: INVESTERMS.COM Registry Domain ID: 986658421_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-05-22T20:26:18Z Creation Date: 2007-05-22T00:03:34Z Registry Expiry Date: 2022-05-22T00:03:34Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS1.STABLETRANSIT.COM Name Server: DNS2.STABLETRANSIT.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-15T08:14:00Z <<< |